Search results
1 – 10 of 11
Officials announced science and technology innovation as the top priority for 2024. The overall tone was supportive of economic growth, with announcements including backing for…
Details
DOI: 10.1108/OXAN-DB284203
ISSN: 2633-304X
Keywords
Geographic
Topical
Expatriates are leaving, businesses are faltering and the local population is grumbling. Authorities see a significant role for small-to-medium enterprises (SMEs) in general, and…
Details
DOI: 10.1108/OXAN-DB254579
ISSN: 2633-304X
Keywords
Geographic
Topical
Entrepreneurship in China.
Details
DOI: 10.1108/OXAN-DB228003
ISSN: 2633-304X
Keywords
Geographic
Topical
Despite sluggish growth, Latin America’s largest financial system saw a return to loan expansion in 2018 after two consecutive years of year-on-year declines.
Details
DOI: 10.1108/OXAN-DB242193
ISSN: 2633-304X
Keywords
Geographic
Topical
As Australia seeks to manage slower demand from China and depressed commodities prices, Prime Minister Malcolm Turnbull has called a 'double dissolution' election for July 2…
Details
DOI: 10.1108/OXAN-DB211578
ISSN: 2633-304X
Keywords
Geographic
Topical
Developments in the global iron ore market
Details
DOI: 10.1108/OXAN-DB211064
ISSN: 2633-304X
Keywords
Geographic
Topical
In October, it signed a landmark green economy deal with Australia. The Financial Services Industry Transformation Map (ITM) 2025 released by the Monetary Authority of Singapore…
Details
DOI: 10.1108/OXAN-DB274529
ISSN: 2633-304X
Keywords
Geographic
Topical
This spending is needed as manufacturers are under pressure to re-engineer their businesses by deploying technologies to enhance productivity and develop and scale new products…
Details
DOI: 10.1108/OXAN-DB243754
ISSN: 2633-304X
Keywords
Geographic
Topical
This was on top of a record 3.2 billion dollars of new investment capital raised by such companies in the first half of the year. Start-up fundraising, a key metric of…
Details
DOI: 10.1108/OXAN-DB238213
ISSN: 2633-304X
Keywords
Geographic
Topical
Outlook for healthcare and pharmaceutical M&A.